MJBizDaily
Federal marijuana rescheduling means institutional capital is coming to cannabis investing
Latest Posts
Illinois cannabis sales increase to record levels amid price drop
Annual sales took a double-digit nosedive even as retailers saw their busiest month on record.
News October 13Canadian cannabis company Organigram enters fight for Aurora
British American Tobacco's stake in Organigram could put it in the middle of the Aurora takeover fight before Curaleaf's bid expires Dec. 4.
October 13Legacy medical cannabis cultivator Bedrocan declared bankrupt in Netherlands
A Dutch court on Thursday declared Bedrocan, the country's lone medical cannabis supplier, bankrupt following the end of its contract with the Netherlands' health ministry.
News October 9What Happens When AI Stops Just Finding Problems, And Starts Acting On Them?
Cannabis operators are collecting more video and operational data than ever. Today’s opportunity is using agentic AI to help teams spot important issues sooner and act before they become bigger…
October 8Here’s what products Ohio cannabis stores can no longer sell
Ohio cannabis retailers can no longer sell certain products, including high potency vaporizers, after new state rules took effect Tuesday. In August, the DCC set new potency and package limits…
News October 8Washington state to tweak cannabis rules to comply with federal marijuana rescheduling
Washington state cannabis regulators signed off on a tweak to state rules that would allow operators to more clearly comply with new federal
News October 8Georgia medical cannabis continues to grow rapidly despite lack of DEA guidance
Georgia's medical cannabis program continues to rapidly expand, but state regulators say they need more input from the U.S. Drug Enforcement Administration.
News October 7Third New Jersey cannabis operator sues to overturn labor peace requirement
Veteran-owned The Cannabis Place says it can't secure a labor-peace agreement and faces losing its license.
News October 7Medical cannabis authorizers up 16% – what it means for operators
Medical cannabis authorizers have grown 16% since 2020, and CDC data shows 69% of clinicians see medical value.
News October 6Curaleaf increases price for Aurora Cannabis hostile takeover bid
Curaleaf built its $5-per-share Aurora offer from public data and says shareholders deserve a fair process if other parties get diligence.
News October 5














